Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

DN604: A platinum(II) drug candidate with classic SAR can induce apoptosis via suppressing CK2-mediated p-cdc25C subcellular localization in cancer cells

Journal Article · · Experimental Cell Research
; ; ;  [1]
  1. Jiangsu Province Hi-Tech Key Laboratory for Biomedical Research, Pharmaceutical Research Center and School of Chemistry and Chemical Engineering, Southeast University, Nanjing, 211189 (China)
Highlights: • DN604 exhibited stronger comparable cytotoxicity to cisplatin. • DN604 showed more potent in vivo antitumor activity than carboplatin. • DN604 resulted in negligible toxic effects as the same effect as cisplatin in vivo. • DN604 could suppress CK2-induced p-cdc25C activation and subcellular localization. DN604, a carboplatin analogue with a functional dicarboxylato ligand, was deeply investigated to explore its ability to induce apoptosis as well as its antitumor mechanism of action. Both in vitro and in vivo assays indicated that DN604 could effectively inhibit cell viability of SGC-7901 gastric cancer cells and exhibited stronger antitumor activity than carboplatin and comparable activity to cisplatin. Significantly in contrast to cisplatin, DN604 resulted in negligible toxic effects in vivo with the same tumor growth inhibition effect as cisplatin. The mechanism study indicated that DN604 inhibited CK2-phosphorylated cdc25C activation to decrease p-cdc25C subcellular localization, leading to the inactivation of cdc2/Cyclin B and G2/M cell cycle arrest and apoptosis in SGC-7901 cancer cells. Our research revealed for the first time that the dicarboxylato ligand containing a suitable functional moiety as the leaving group in the platinum(II) complex can effectively induce cell cycle arrest and apoptosis via inhibiting key checkpoint proteins.
OSTI ID:
23082441
Journal Information:
Experimental Cell Research, Journal Name: Experimental Cell Research Journal Issue: 1 Vol. 364; ISSN 0014-4827; ISSN ECREAL
Country of Publication:
United States
Language:
English

Similar Records

Jaridonin-induced G2/M phase arrest in human esophageal cancer cells is caused by reactive oxygen species-dependent Cdc2-tyr15 phosphorylation via ATM–Chk1/2–Cdc25C pathway
Journal Article · Wed Jan 14 23:00:00 EST 2015 · Toxicology and Applied Pharmacology · OSTI ID:22465685

Identification of hematein as a novel inhibitor of protein kinase CK2 from a natural product library
Journal Article · Tue May 05 20:00:00 EDT 2009 · BMC Cancer · OSTI ID:1626530

COX-2/sEH Dual Inhibitor PTUPB Potentiates the Antitumor Efficacy of Cisplatin
Journal Article · Wed Dec 27 19:00:00 EST 2017 · Molecular Cancer Therapeutics · OSTI ID:1438685